HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas

Abstract : Aggressive primary cutaneous T-cell lymphomas include advanced-stage mycosis fungoides (stage ≥ IIB mycosis fungoides), Sézary syndrome, gamma/delta cutaneous lymphoma, nasal type lymphoma, aggressive epidermotropic CD8+ T-cell lymphoma and some cutaneous lymphomas not otherwise specified. To evaluate their long-term prognosis, we conducted a retrospective cohort study of 85 patients diagnosed between 2005 and 2020 with advanced-stage mycosis fungoides (n = 48), Sézary syndrome (n = 28) or aggressive non-mycosis fungoides/Sézary syndrome subtypes (n = 9). The median survival times in these 3 groups were 118.7, 45.7 and 11.2 months, respectively, and the 5-year survival rates were 55.3%, 27.8% and 33.3%, respectively. Multivariate analyses in patients with mycosis fungoides/Sézary syndrome identified age ≥ 70 years, Eastern Cooperative Oncology Group Performance Status ≥ 2, and the high-risk group according to the Cutaneous Lymphoma International Consortium prognostic model, as adverse prognostic factors. Seven patients in this mycosis fungoides/Sézary syndrome group were in complete long-term remission after treatment with bexarotene, including 4 patients living without any treatment for 16–101 months.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-reims.fr/hal-03602605
Contributor : Valerian Dormoy Connect in order to contact the contributor
Submitted on : Wednesday, March 9, 2022 - 11:28:49 AM
Last modification on : Wednesday, March 9, 2022 - 11:29:14 AM

Links full text

Identifiers

Collections

Citation

Joséphine Franceschi, Marine Ehret, Laetitia Visseaux, Anne Durlach, Coralie Barbe, et al.. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas. Acta Dermato-Venereologica, Society for Publication of Acta Dermato-Venereologica, 2022, ⟨10.2340/actadv.v102.1087⟩. ⟨hal-03602605⟩

Share

Metrics

Record views

7